《Swiss Medical Weekly》重点专注发布医学-医学:内科领域的新研究,旨在促进和传播该领域相关的新技术和新知识。鼓励该领域研究者详细地发表他们的高质量实验研究和理论结果。该杂志创刊至今,在医学-医学:内科领域,有较高影响力,对来稿文章质量要求较高,稿件投稿过审难度较大。欢迎广大同领域研究者投稿该杂志。
CiteScore | SJR | SNIP | CiteScore排名 | |||
---|---|---|---|---|---|---|
5 | 0.519 | 0.533 | 学科类别 | 分区 | 排名 | 百分位 |
大类:大类:Medicine
小类:小类:GeneralMedicine
|
Q1 | 101/636 | 84% |
按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
---|---|---|---|---|
学科:MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | 96 / 325 | 70.6% |
按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
---|---|---|---|---|
学科:MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | 109 / 329 | 67.02% |
文章名称
引用次数
Trends in influenza vaccination uptake in Switzerland: Swiss Health Survey 2007 and 2012
10
Vascular endothelial growth factor biology for regenerative angiogenesis
8
Clinical outcomes in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: a retrospective analysis of results from the OBSErve study in Switzerland
8
Dual use in the 21st century: emerging risks and global governance
8
A digitally facilitated citizen-science driven approach accelerates participant recruitment and increases study population diversity
7
Digital health: meeting the ethical and policy challenges
7
Awareness, approval and completion of advance directives in older adults in Switzerland
6
New insights into the pathophysiology of inflammatory bowel disease: microbiota, epigenetics and common signalling pathways
6
Immunotherapy in head and neck cancer - scientific rationale, current treatment options and future directions
6
The implementation and first insights of the French-speaking Swiss programme for monitoring self-harm
5
国家/地区
发文量
TSwitzerland
2626
TUSA
208
TGERMANY (FED REP GER)
185
TFrance
113
TEngland
110
TItaly
79
TBelgium
62
TCanada
56
TAustralia
49
TNetherlands
47





